secwatch.observer — SEC 8-K summary
======================================

Issuer:     Esperion Therapeutics, Inc. (ESPR)
CIK:        0001434868
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001104659-22-121726
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Esperion enters RIPA amendment with $50M partial call, waiver of defaults
-------------------------------------------------------------------------

- One-time partial call of $50M on Revenue Interests under amended Revenue Interest Purchase Agreement.
- Cumulative Purchaser Payments reduced to $177,777,778.
- Waived certain claimed defaults, breaches and Put Option Events related to new bank account.
- Other material terms of RIPA and Security Agreement remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434868/000110465922121726/0001104659-22-121726-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434868/000110465922121726/tm2231228d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-121726

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer